Quick Answer
BridgeBio Pharma, Inc. reported Shares Outstanding of 194.77 million shares for fiscal year 2025.
BridgeBio Pharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 194.77M | +2.5% |
| 2024 | 190.04M | +8.5% |
| 2023 | 175.08M | +16.2% |
| 2022 | 150.63M | +2.2% |
| 2021 | 147.34M | +19.9% |
| 2020 | 122.85M | -0.7% |
| 2019 | 123.66M | +34.3% |
| 2018 | 92.06M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 192.63M | +1.9% | +0.8% |
| June 30, 2025 | 191.16M | +1.7% | +0.7% |
| March 31, 2025 | 189.83M | +1.4% | -0.1% |
| December 31, 2024 | 190.04M | +8.5% | +0.6% |
| September 30, 2024 | 188.99M | +8.5% | +0.5% |
| June 30, 2024 | 188.03M | +16.5% | +0.5% |
| March 31, 2024 | 187.12M | +16.6% | +6.9% |
| December 31, 2023 | 175.08M | +16.2% | +0.5% |
- BridgeBio Pharma, Inc. showed an increase of +2.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, BridgeBio Pharma, Inc.’s shares outstanding has grown by 111.6% (from 92.06 million shares to 194.77 million shares).
- The most recent figure is from BridgeBio Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: